I am not remotely saying OCC should be at $4.00 - jeez, the heckle brigade would rip me a new one. I was suggesting that if OCC was cash flow positive and growing revenues at 70-100% rates (which it has recently) and partnered by big Pharma (per your complaints) then you would have to pay more like $4.00 a share than $0.40.
Share trading is still risk vs yield, just like all financial assets. There is a risk that OCC doesn't get there, hence the massive yield potential presented by its present low price, should it get actually be partnered and successfully transition to a cash flow positive company.
Absolutely get your frustrations with management, hence I have myself badgered them over the years, to their annoyance, I am sure.
(good reminder to everyone on the Strait manufacturing facilities btw - people so quickly forget).
Ortho-ACL (Rope), page-27
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.005(1.10%) |
Mkt cap ! $96.40M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.5¢ | 45.5¢ | $87.13K | 189.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 271 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 21507 | 1 |
View Market Depth
| Last trade - 15.40pm 04/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |